Mycobacterial mycolic acids trigger inhibitory receptor Clec12A to suppress host immune responses.


Journal

Tuberculosis (Edinburgh, Scotland)
ISSN: 1873-281X
Titre abrégé: Tuberculosis (Edinb)
Pays: Scotland
ID NLM: 100971555

Informations de publication

Date de publication:
01 2023
Historique:
received: 18 10 2022
revised: 05 12 2022
accepted: 11 12 2022
pubmed: 22 12 2022
medline: 1 2 2023
entrez: 21 12 2022
Statut: ppublish

Résumé

Mycobacteria often cause chronic infection. To establish persistence in the host, mycobacteria need to evade host immune responses. However, the molecular mechanisms underlying the evasion strategy are not fully understood. Here, we demonstrate that mycobacterial cell wall lipids trigger an inhibitory receptor to suppress host immune responses. Mycolic acids are major cell wall components and are essential for survival of mycobacteria. By screening inhibitory receptors that react with mycobacterial lipids, we found that mycolic acids from various mycobacterial species bind to mouse Clec12A, and more potently to human Clec12A. Clec12A is a conserved inhibitory C-type lectin receptor containing immunoreceptor tyrosine-based inhibitory motif (ITIM). Innate immune responses, such as MCP-1 production, and PPD-specific recall T cell responses were augmented in Clec12A-deficient mice after infection. In contrast, human Clec12A transgenic mice were susceptible to infection with M. tuberculosis. These results suggest that mycobacteria dampen host immune responses by hijacking an inhibitory host receptor through their specific and essential lipids, mycolic acids. The blockade of this interaction might provide a therapeutic option for the treatment or prevention of mycobacterial infection.

Identifiants

pubmed: 36542980
pii: S1472-9792(22)00131-7
doi: 10.1016/j.tube.2022.102294
pii:
doi:

Substances chimiques

CLEC12A protein, human 0
Lectins, C-Type 0
Mycolic Acids 0
Receptors, Mitogen 0
CLEC12A protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102294

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Naoya Nishimura (N)

Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, 565-0871, Japan; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.

Noriyuki Tomiyasu (N)

Department of Systems Life Sciences, Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, 812-8582, Japan.

Shota Torigoe (S)

Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, 565-0871, Japan; Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, 189-0002, Japan; Management Department of Biosafety, Laboratory Animal, and Pathogen Bank, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.

Satoru Mizuno (S)

Research and Development Department, Japan BCG Laboratory, Tokyo, 204-0022, Japan.

Hanako Fukano (H)

Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, 189-0002, Japan.

Eri Ishikawa (E)

Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, 565-0871, Japan; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, 565-0871, Japan.

Harutaka Katano (H)

Department of Pathology, National Institute of Infectious Disease, Tokyo, 162-8640, Japan.

Yoshihiko Hoshino (Y)

Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, 189-0002, Japan.

Kazuhiro Matsuo (K)

Research and Development Department, Japan BCG Laboratory, Tokyo, 204-0022, Japan.

Masatomo Takahashi (M)

Department of Systems Life Sciences, Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, 812-8582, Japan; Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan.

Yoshihiro Izumi (Y)

Department of Systems Life Sciences, Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, 812-8582, Japan; Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan. Electronic address: izumi@bioreg.kyushu-u.ac.jp.

Takeshi Bamba (T)

Department of Systems Life Sciences, Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, 812-8582, Japan; Division of Metabolomics, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan.

Koichi Akashi (K)

Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.

Sho Yamasaki (S)

Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, 565-0871, Japan; Laboratory of Molecular Immunology, Immunology Frontier Research Center, Osaka University, Suita, 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University (CiDER), Suita, 565-0871, Japan; Division of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba, 260-8673, Japan; Division of Molecular Design, Research Center for Systems Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, 812-8582, Japan. Electronic address: yamasaki@biken.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH